Taxane containing regimens for the adjuvant treatment of early breast cancer

  • Protocol
  • Intervention


  • A Nowak,

  • M Stockler,

  • N Wilcken,

  • D Ghersi

Dr Anna Nowak, Medical Oncologist and Senior Lecturer, Department of Medical Oncology, Sir Charles Gardiner Hospital and University of Western Australia, B Block, Hospital Avenue, Nedlands, Perth, WA, 6099, AUSTRALIA.


This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to compare taxane containing adjuvant chemotherapy regimens with adjuvant regimens not containing a taxane in the management of women with operable breast cancer. Regimens include:

  • Regimen A plus taxane vs Regimen A

  • Regimen A plus taxane vs Regimen B

  • Regimen A with taxane substituted for one or more drugs vs Regimen A